Clinical Trials in Georgia

Showing 3301-3320 of 19,050 trials

Abatacept as GVHD Prophylaxis Phase 2

NCT01743131

This is a phase II multi-center, randomized, double blind, placebo-controlled trial. The investigators are doing this study to see if a new drug, abatacept, can be used together with a calcineurin inhibitor (cyclosporine or tacrolimus) and methotrexate to provide better protection against Acute Graft versus Host Disease (aGvHD) without causing more infections.

Graft vs Host DiseaseMalignancy

Boston Children's Hospital186 participantsStarted Feb 2013

Los Angeles, California, United States • Oakland, California, United States • Aurora, Colorado, United States +11 more locations

COMPLETEDPhase 365 miles

A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

NCT05628103

This study evaluated how well SEP-363856 works and how safe it is in people with schizophrenia that switch to SEP-363856 from their current antipsychotic medication.

Schizophrenia

Otsuka Pharmaceutical Development & Commercialization, Inc.101 participantsStarted Dec 2022

Anaheim, California, United States • Bellflower, California, United States • Culver City, California, United States +22 more locations

Abatacept as GVHD Prophylaxis Phase 2

A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

Find Trials by Condition in Georgia

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

CapTemY90 for Grade 2/3 NET Liver Metastases

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome

Evaluation of A Clinical Diagnostic Test for CRDS

Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)